Matthew B. Stanbrook
University of Toronto
201 Papers
926 Citations
Matthew B. Stanbrook is an academic researcher from University of Toronto. The author has contributed to research in topics: Medicine & COPD. The author has an hindex of 20, co-authored 183 publications. Previous affiliations of Matthew B. Stanbrook include Toronto Western Hospital & University Health Network.
Chat about Author
Papers
Cardiovascular Safety of Inhaled Long-Acting Bronchodilators in Individuals With Chronic Obstructive Pulmonary Disease
Andrea S. Gershon,Ruth Croxford,Andrew Calzavara,Teresa To,Teresa To,Matthew B. Stanbrook,Ross E.G. Upshur,Ross E.G. Upshur,Ross E.G. Upshur,Therese A. Stukel,Therese A. Stukel +10 more
TL;DR: Among older individuals with COPD, new use of long- acting β-agonists and anticholinergics is associated with similar increased risks of cardiovascular events, and close monitoring of COPD patients requiring long-acting bronchodilators is needed regardless of drug class.
177
A 1980 Letter on the Risk of Opioid Addiction
TL;DR: A five-sentence letter published in the Journal in 1980 has been heavily cited as evidence that long-term opioid therapy has seldom been associated with addiction, and of the 608 citations, 72.2% used the letter uncritically as proof that addiction was rare.
174
A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals.
Peter C. Austin,Peter C. Austin,Andrea Manca,Merrick Zwarenstein,Merrick Zwarenstein,Merrick Zwarenstein,David N. Juurlink,David N. Juurlink,Matthew B. Stanbrook,Matthew B. Stanbrook +9 more
TL;DR: The findings suggest the need for greater editorial consistency across journals in the reporting of RCTs and there is a needs for greater debate about the relative merits of unadjusted vs. adjusted estimates of treatment effect.
164
SYSTEMATIC REVIEWS A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals
Peter C. Austin,Andrea Manca,Merrick Zwarenstein,David N. Juurlink,Matthew B. Stanbrook +4 more
- 01 Jan 2010
TL;DR: In this paper, the authors examined 114 randomized controlled trials (RCTs) published in the New England Journal of Medicine, the Journal of the American Medical Association, The Lancet, and the British Medical Journal between January 1, 2007 and June 30, 2007.
115
Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma.
TL;DR: Gender differences were observed in the association between COPD and asthma and higher nicotine addition levels in current smokers, and these findings could in part explain population trends showing that COPd and asthma are increasing more rapidly in women.
98